Fig. 1: Study design and genomic analysis of benign EMPs.

A Schematic of overall experimental strategy for genomic analysis of EMPs. B Case matrix of clinical parameters and mutations in EMPs from 31 patients.

A Schematic of overall experimental strategy for genomic analysis of EMPs. B Case matrix of clinical parameters and mutations in EMPs from 31 patients.